Gregory Fraser

Stock Analyst at Truist Securities

(2.02)
# 976
Out of 5,329 analysts
40
Total ratings
50.00%
Success rate
29.92%
Average return
13 Stocks
Name Action PT Current % Upside Ratings Updated
ANIP ANI Pharmaceuticals
Maintains: Hold
62 65
70.81 -8.21% 9 Apr 21, 2025
JAZZ Jazz Pharmaceuticals
Maintains: Strong Buy
220 230
117.19 96.26% 1 Mar 6, 2025
BHC Bausch Health Compan...
Maintains: Hold
8 7
5.29 32.33% 2 Jul 25, 2024
XAIR Beyond Air
Maintains: Buy
10 8
0.21 3709.52% 6 Apr 30, 2024
BTMD Biote
Maintains: Buy
10 9
3.29 173.56% 2 Jan 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
6 7
7.74 -9.56% 4 Nov 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
26 29
71.72 -59.56% 5 Aug 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
95
17.98 428.36% 3 Jun 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
14 18
11.86 51.77% 2 May 26, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
45 40
14.7 172.11% 2 May 26, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 1 Aug 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
7 3
n/a n/a 2 May 17, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
7 6
n/a n/a 1 Apr 14, 2022